Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Healthcare
Ogletree, Deakins, Nash, Smoak & Stewart
With the number of U.S. residents aged 65 and older projected to more than double from 46 million today to over 98 million by 2060, home care agencies face a litany of difficulties
Oblon, McClelland, Maier & Neustadt, L.L.P
The Internet of Medical Things (IoMT) is a hot topic in the world of medical devices. This summer, at the MedTech conference in Philadelphia, IoMT was the word on everyone's lips.
Holland & Knight
HIPAA and several other privacy laws do not include a private right of action
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) has announced a new proposed reimbursement model for certain Medicare Part B drugs and biologicals.
Reed Smith
Plaintiff Kevin McCann launched a putative class action against The UCAN Company ("UCAN")
Foley Hoag LLP
In a wide-ranging speech on CMS's efforts to lower Medicaid drug costs, Administrator Seema Verma announced yesterday that CMS ...
Shearman & Sterling LLP
Associate Timothy Slattery (Antitrust-Washington, DC) has contributed to the Pharmaceutical Industry Antitrust Handbook (2nd Ed.) published by the American Bar Association
Seyfarth Shaw LLP
One of the latest efforts by a municipality to address public health concerns by requiring warnings on certain products may be revived depending on the outcome of a recent rehearing before
Foley Hoag LLP
On November 13, 2018 CMS (as mandated by Congress in the 21st Century cures Act) issued a State Medicaid Director Letter providing states with guidance on both
Mintz
As our use of AI technology becomes more frequent, interconnected, and integral to daily life, the liability exposure to AI product designers and manufacturers continues to escalate
Foley & Lardner
Takeaway Message: Except in limited circumstances, current regulatory guidance prohibits an employer from maintaining a health reimbursement arrangement
Bowditch & Dewey
On or before November 30, 2018, every Massachusetts employer that had six or more employees in any month during the past year must file a "Health Insurance Responsibility Disclosure" (HIRD) form.
Mintz
In a three-sentence order issued on October 29th, the Tenth Circuit Court of Appeals declined to grant a Request for Rehearing in the closely watched Polukoff case.
Sheppard Mullin Richter & Hampton
Lynsey Mitchel By Eric Klein, Lynsey Mitchel and John Tilton* on November 13, 2018 Posted in Healthcare Law, Prescription Drug Issues California recently passed Assembly Bill 315 to create greater regulatory oversight of pharmacy benefit managers ("PBMs").
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) has issued the Calendar Year (CY) 2019 Final Rule that updates payment rates and policy changes in the Hospital Outpatient Prospective Payment System
Mintz
This week, Congress returns to Washington for its lame duck session with uncertain expectations for what gets done between now ...
Mintz
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the "SUPPORT for Patients and Communities Act")
BakerHostetler
The FDA issued a report on the prevalence of food-borne illness risk factors in fast-food and full-service restaurants. The results are part of the first phase of a 10-year study on the issue.
Sheppard Mullin Richter & Hampton
Tuesday's midterm elections showed that healthcare is now a top issue among voters, according to exit polls.
Dentons
On October 29, 2018, Deputy Secretary of the U.S. Department of Health and Human Services (HHS) Eric Hargan announced the official opening of the Health Sector Cybersecurity Coordination Center (HC3).
Latest Video
Most Popular Recent Articles
Jones Day
On the heels of the European Union's General Data Protection law, which went into effect in May 2018
Ropes & Gray LLP
On October 24, 2018, the President signed a far-reaching bill addressing issues related to opioid use and abuse—the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018.
Mintz
Once finalized, the draft guidance will supersede a final guidance of the same name issued in 2014.
Foley Hoag LLP
Earlier this year, the Department of Justice, Civil Division, issued two policy memos that will directly affect its civil enforcement priorities, particularly with regard to healthcare and life sciences companies.
Thompson Coburn LLP
There are three initiatives on Missouri's November 6, 2018, ballot that seek to make medical cannabis legal under Missouri state law.
Mintz
With the midterms in sight, our lame duck preview takes a look ahead at what the balance of the year will look like in health care.
Reed Smith
The Office of the Inspector General (OIG) published a report in September 2018 after a review of the Food and Drug Administration's (FDA) policies, procedures, and guidance relating to cybersecurity reviews of networked medical devices
Arnold & Porter
While congressional Republicans safely hold the majority, we anticipate strong efforts to advance their legislative agenda.
Sheppard Mullin Richter & Hampton
As detailed in previous posts in this series, one major objective that the Centers for Medicare and Medicaid Services ("CMS") addressed in a proposed rule issued November 1, 2018 (the "Proposed Rule").
Duff and Phelps
The market is experiencing tremendous growth due to the reduction in overall cost and decrease in time required to bring a product to market.
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with